About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Cardiovascular Medicine
›
Top Articles
Journal of Cardiovascular Medicine
1.9
(top 9%)
Impact Factor
2.1
(top 9%)
extended IF
45
(top 9%)
H-Index
1.7K
authors
3.2K
papers
20.1K
citations
2.8K
citing journals
14.5K
citing authors
Most Cited Articles of Journal of Cardiovascular Medicine
Title
Year
Citations
The role of dietary n-6 fatty acids in the prevention of cardiovascular disease
2007
88
Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial
2006
83
A retrospective multicenter study on long-term prevalence of chronic pain after cardiac surgery
2015
78
Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure
2007
78
Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis
2010
75
Triage and management of pericardial effusion
2010
70
Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study
2010
69
The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study
2015
67
Gender determinants of cardiovascular risk factors and diseases
2010
66
Guideline recommendations for heart complications in thalassemia major
2008
66
The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review
2010
65
Protection of organs other than the heart by remote ischemic conditioning
2013
64
Task force on: 'Early markers of atherosclerosis: influence of age and sex'
2013
63
Aetiological diagnosis in acute and recurrent pericarditis: when and how
2009
62
Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials
2010
62
Heart and tumors: location, metastasis, clinical manifestations, diagnostic approaches and therapeutic considerations
2008
59
Hyperuricaemia: more than just a cause of gout?
2013
58
Vascular endothelial growth factors in cardiovascular medicine
2008
58
The two faces of miR-29
2015
57
Echocardiography in the diagnosis and management of pericardial disease
2006
57
Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations
2009
56
Aortic dilatation in patients with bicuspid aortic valve
2006
54
Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study
2006
54
Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention
2010
53
Cardiovascular risk in women with polycystic ovary syndrome
2008
52
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.